Healthtech & Wellness VC Funds

Vamos Ventures is a Los Angeles-based venture capital firm dedicated to investing in diverse founders, particularly from the Latinx community. Founded by Marcos Gonzalez in 2018, Vamos Ventures focuses on early-stage, tech-driven companies with the potential for high financial returns and significant social impact. The firm's primary investment sectors include Health & Wellness, Future of Work, FinTech, and Sustainability​. Notable investments in their portfolio include Form Energy, a company revolutionizing energy storage; Suma Wealth, a fintech platform focused on financial inclusion for the Latinx community; and SweetBio, a health and wellness startup innovating in wound care​. Vamos Ventures' mission is to create alpha and impact by funding disruptive solutions led by Latinx and diverse founders. The firm emphasizes the importance of community empowerment, social mobility, and representation in the tech ecosystem. They are supported by notable partners such as Apple, Bank of America, and the Ford Foundation​.

Van Herk Ventures is the life-sciences investment arm of Van Herk Groep, the Rotterdam-based family investment group built by Dutch entrepreneur Adriaan van Herk and whose roots trace back to 1951. Operating with patient, evergreen family capital, Van Herk Ventures invests in the life-sciences sector through direct stakes in both private and publicly listed companies as well as commitments to specialist venture capital funds. For private companies it concentrates on the Benelux region and typically participates in businesses with an enterprise value of between roughly EUR 10 million and EUR 150 million at the time of first investment, while its public-market positions extend across the broader European and global biotech landscape, generally as a co-investor. The wider Van Herk Groep deploys across real estate, energy, financial services and construction, but the Ventures vehicle is focused squarely on life sciences, biotechnology and healthtech. Across roughly 28 portfolio companies it has produced eight IPOs and seven acquisitions, with a track record that includes some of Europe's most prominent biotech names, argenx, Merus, Galapagos, Zealand Pharma, BioInvent, DCprime and DermTech, alongside landmark exits such as Ablynx, acquired by Sanofi, and Crucell, acquired by Johnson & Johnson. The group runs a lean team of around ten people including two partners. Backed by patient, multigenerational family capital, Van Herk Ventures takes long-term positions across private and public European life-sciences companies and has built one of the region's most successful biotech investment track records.

Van Wickle Ventures (VWV) is a student-run, evergreen venture fund affiliated with Brown University, founded in 2019 and based at the Nelson Center for Entrepreneurship in Providence, Rhode Island. Co-founded by Sophie Starck and John Diorio and seeded with a gift from Robert and Erna Place, the fund invests $25,000 to $50,000 checks drawn from Brown's endowment into startups founded by Brown and RISD students, alumni and professors, investing across all early stages from pre-seed and seed through seed-plus and Series A, generally as a co-investor. The fund is one of the few fully student-run vehicles deploying real institutional capital: throughout the academic year students source and rigorously diligence prospective companies, then present opportunities to an investment committee of seasoned alumni venture capitalists, drawn from funds such as Pear VC and Alumni Ventures, who vote on the final investment decision. As an evergreen fund, all returns are reinvested so that VWV remains a permanent supporter of Brown's entrepreneurial ecosystem while training the next generation of investors in sourcing, diligence and decision-making. To date the fund has sourced more than 700 Brown-founded companies and built a portfolio of roughly 13 startups, including Minded, Apprenta, Ghia and Otis, with its most recent disclosed investment being Lexi at the pre-seed stage in February 2026. By deploying endowment capital into companies founded by the Brown and RISD community and recycling its returns, Van Wickle Ventures supports the university's entrepreneurial ecosystem and develops student investors.

Vanedge Capital is an early-stage venture capital firm with offices in Vancouver and Silicon Valley. Founded by experienced technology entrepreneurs, the firm focuses on investing in companies that leverage deep technology and innovative solutions in areas such as hard tech, artificial intelligence, and analytics. Vanedge Capital aims to help visionary technologists build and scale their businesses through capital investment, operational expertise, and a robust network of industry connections. The firm has $390 million under management and has developed a repeatable investment process refined over a decade to deliver superior returns. Their portfolio includes a diverse range of companies such as Canalyst, Cogniac, and Echodyne, each known for their groundbreaking technologies and market impact. Key team members include Moe Kermani, who has extensive experience in cloud computing and machine intelligence, and Amy Rae, who focuses on SaaS businesses and applied analytics. The team provides hands-on support to their portfolio companies, helping them mitigate execution risks and attract follow-on capital from top-tier co-investors.

Vanguard Ventures was an early-stage venture capital firm founded in 1981 that helped entrepreneurs build pioneering technology and life-science companies. Co-founded by Jack M. Gill, the firm was based in California's Silicon Valley, in San Jose and Palo Alto, with an additional office in Houston, Texas, and invested across software, information technology, telecommunications, medical devices, biotech and healthtech, willing to lead. Over its life Vanguard managed roughly $500 million across about seven to eight funds, the last being Vanguard VII LP, and was the lead investor in more than 100 technology and medical-device startups, ultimately returning over $1 billion, approximately 7x, to its investors. Its portfolio and exits included some landmark companies of the 1990s and 2000s, among them Ciena, Network Appliance, Aldus, Macromedia, Vocera Communications, Advanced Fibre Communications, Digital Island, Hansen Medical, EndoSonics, Mycogen, CardioGenesis, Cooking.com, DFine, Vormetric, Salient Surgical Technologies and ZipRealty. Founder Jack Gill was a scientist, executive, entrepreneur and philanthropist who had earlier founded Autolab, a pioneer of microprocessor-based instruments for chromatography that was acquired by Spectra Physics, and who later taught entrepreneurship and helped lead the Houston-based GOOSE Capital angel network. Vanguard Ventures is now a legacy firm whose funds have wound down and is no longer actively investing. Across two decades it built a strong track record as a lead early-stage backer of technology and medical-device companies, returning roughly seven times invested capital to its limited partners.

Vast Ventures is a venture capital firm that focuses on investing in disruptive companies with a global impact. Founded in 2004 by Doug Chertok, the firm is headquartered in New York, New York. Vast Ventures has a diverse portfolio, investing in sectors such as healthcare, finance, AI, cloud software, and sustainability. They have a strong track record with notable investments in companies like Sweetgreen, Conductor, and Clover Health​. The firm's investment strategy centers on fostering innovation and supporting entrepreneurs who aim to create significant positive change. They emphasize long-term partnerships, providing not just capital but also strategic guidance and support to help their portfolio companies grow and succeed​. Vast Ventures is managed by a team of experienced professionals, including Doug Chertok, Aniq Rahman, and Talia Zapolanski. The team leverages their extensive backgrounds in finance, entrepreneurship, and venture capital to help startups navigate the challenges of early-stage growth​. For startups seeking investment, Vast Ventures is particularly interested in companies that aim to improve health and happiness, promote resource sustainability, increase human potential and productivity, and foster knowledge and empathy. They prefer to lead investment rounds and take active roles in the development of their portfolio companies​.

Vectors Capital is a venture capital firm focused on addressing global challenges, particularly in the fields of climate and sustainability. Their investment thesis centers around supporting early-stage startups in sectors like sustainable energy, low-carbon mobility, and resource optimization. They also emphasize innovations in synthetic biology (SynBio), with a dedicated SynBio x Climate Fund aimed at backing startups using biology to combat climate change. Their portfolio typically includes companies working on solutions that align with the UN Sustainable Development Goals, such as alternative proteins, carbon sequestration, and clean energy technologies. They take a hands-on approach with startups, often leading investment rounds and offering mentorship through their Vectors Angel network, a global community of seasoned investors committed to impact investing. For startups seeking investment, Vectors Capital looks for those developing scalable technologies that can deliver both financial returns and social impact. They also encourage their portfolio companies to sign the Vectors Impact Pledge, committing to measurable long-term impact goals. Investors can engage through various programs, including the SynBio x Climate initiative, which focuses on cutting-edge biotechnology solutions for environmental sustainability.

Vega Ventures is a partnership-driven private equity and venture capital firm founded in 2016 and based in Madeira Beach, Florida, taking its name from the bright star Vega to reflect a mission of serving as a guiding force in the investment landscape. The firm runs a dual strategy: a private-equity arm that acts as a hands-on operator, at times taking the helm to overhaul strategy and operations across hospitality and real estate, industrials, consumer and distribution, essential services and climate and sustainability, and a venture capital arm that partners with visionary founders, providing early-stage capital and strategic support to scale disruptive ideas into market leaders. Its sector focus is intentionally diverse, blending the high-growth potential of next-generation technology, software, AI and data analytics spanning SaaS, commerce, fintech, healthtech, insurtech and cybersecurity, with stable, asset-heavy traditional industries, life sciences and healthcare, and agriculture, agritech and food innovation. Vega emphasises patient, long-term capital, active management, global expansion and a data-driven, technology-enabled investment process, generally as a co-investor. On the venture side it has made roughly eight disclosed investments with about three exits; portfolio companies include the German digital-health startup neotiv, the entertainment-software company The Animal Age and the decentralized-finance protocol BurgerSwap, with its most recent disclosed venture investment being The Animal Age in July 2023. By combining a hands-on private-equity operating model with early-stage venture investing across technology and asset-heavy industries, Vega Ventures backs founders and companies it can actively help build and scale.

Velvet Sea Ventures is a multi-stage venture capital firm based in New York, founded in 2019 by Kass Lazerow, Matthew Giampetroni, Michael Lazerow, and John Giampetroni. The firm focuses on helping entrepreneurs turn their visions into reality by providing capital and hands-on strategic support. With over 80 years of combined experience and more than $2.2 billion invested, Velvet Sea offers seed-to-growth stage investments across various sectors. The firm is known for backing high-growth companies in industries like human capital services, fintech, and semiconductors. Their diverse portfolio includes companies such as Scopely, Liquid Death, SuperRare, and eToro, emphasizing Velvet Sea's versatility in supporting businesses from gaming to consumer products. Velvet Sea Ventures takes pride in being more than just a capital provider; they partner closely with their portfolio companies to drive innovation and long-term success. Their team has led numerous high-profile investments, including in Autograph and LeoLabs, and they continue to expand their reach across various sectors globally.

Venrock, a venture capital firm born from the Rockefeller family’s pioneering investments, focuses on early-stage companies in healthcare and technology. Its portfolio features high-profile companies like Apple, Intel, and more recently, businesses such as Illumina, and Cloudflare. Venrock operates primarily in the U.S., with offices in Palo Alto, New York, and Cambridge, emphasizing innovation-driven startups. Venrock’s investment strategy targets disruptive ideas in digital health, biotech, enterprise software, and cybersecurity. They prioritize early-stage investments, often leading seed and Series A rounds with checks typically ranging from $5M to $10M. The firm’s disciplined approach includes follow-on investments, ensuring sustained growth. Venrock tends to stay hands-on, offering strategic guidance rather than merely financial support, particularly in sectors with complex technical or regulatory landscapes. With recent funds like Venrock 10, a $650M pool, the firm is increasingly active, especially in biotech and digital therapeutics. Founders should note that Venrock values data-driven pitches and prefers founders with strong domain expertise. Partner Bryan Roberts, a key figure, exemplifies Venrock’s deep involvement in healthcare innovation, while other partners like Brian Ascher are notable for their tech focus. For startups, the ideal approach to Venrock involves showcasing clear scalability and a transformative market vision. Venrock’s long-standing reputation for backing groundbreaking companies is cemented by its proactive role in nurturing bold ideas that shape the future.

Venture Investors Health Fund, also known as Venture Investors and more recently rebranded Clarevia, is one of the Midwest's longest-established healthcare-dedicated venture capital firms, headquartered in Madison, Wisconsin with an office in Ann Arbor, Michigan. Tracing its roots to the early 1980s, when it began as Madison Capital Corporation with just $1M under management, the firm has built a roughly four-decade legacy and today manages around $350M in assets. It invests in early-stage healthcare and life-sciences companies developing patient-facing innovations across biopharmaceuticals and therapeutics, medical devices, diagnostics and tools, and digital health, with historical strength in oncology, infectious disease and ophthalmology and an expanding focus on behavioral and women's health, willing to lead. The firm prefers companies with a Midwest presence but national reach, leveraging its proximity to world-class research universities. In its most recent, seventh, fund it closed $80M, with first-check sizes ranging from $500,000 to $4M and similar or larger amounts reserved for follow-on rounds. New portfolio companies funded include Elephas Biosciences, Rivermark Medical, Sanacor, Ten Bay Bio and EarliTec Diagnostics. Over its history the firm has made well over 100 investments and recorded roughly 50 exits. Its leadership includes Executive Managing Director Jim Adox, longtime Managing Director John Neis, with the firm since 1985, and Principal Jenni Le. By concentrating exclusively on healthcare and life sciences and leveraging its university ties, Venture Investors Health Fund backs early-stage, patient-facing innovation across the Midwest and beyond.

Venture Kick, a leading philanthropic initiative in Switzerland, has been instrumental in supporting early-stage startups since its inception in 2007. The program provides up to CHF 150,000 in pre-seed funding through a structured, three-stage process, aimed at helping science-based startups transition from innovative concepts to market-ready businesses. With a portfolio of over 1,000 supported startups, Venture Kick has contributed significantly to the Swiss startup ecosystem. Their efforts have led to the creation of more than 13,300 jobs and attracted over CHF 8 billion in investments. Notable successes from their alumni include Climeworks, a leader in direct air capture technology, which recently raised CHF 600 million to scale its operations, and YASAI, a vertical farming company that has secured investment from the Bell Food Group to boost its growth​​. The foundation’s focus spans various high-tech sectors, including ICT, life sciences, cleantech, and advanced manufacturing. In 2023 alone, Venture Kick reviewed 781 applications and supported 118 projects, demonstrating its robust selection process and broad industry impact. The initiative aims to scale its model further, with ambitious goals of supporting 3,000 high-tech companies and creating 100,000 jobs by 2033​.

VentureIsrael is an Israeli early-stage deep tech venture capital fund that backs founders building breakthrough technology from seed to scale across quantum, space, neuro, semiconductors, AI infrastructure, cybersecurity and digital health. Its thesis centers on timing, investing where readiness, urgency and adoption are beginning to align, a defensible deep tech moat, and companies that can either dominate a market or force a fast acquisition; the fund describes itself as market-agnostic but conviction-driven on technology, time-to-market and people, and it is willing to lead. The firm is led by Managing Partners Rafael (Roman) Gold and Gadi Isaev, who have built the Israeli tech ecosystem together for more than 12 years across five joint ventures, supported by venture partners including Gil Don (Wib, acquired by F5), Ran Bar-Yosef (Spectralics) and Arkady Karpman (Rapyd co-founder and CTO), plus scientific advisors such as Prof. Shlomi Dolev and Prof. Simon Litsyn, co-inventor of the USB flash drive. Collectively the partners have made more than 50 investments in Israeli startups with over 10 exits and helped channel over $500M of VC funding into the country; their first fund ranks top-quartile by IRR and top-decile by DPI for its vintage. In May 2025 VentureIsrael launched its second fund, around $25M, to back roughly 20 Series A companies. Portfolio names include SSI (Safe Superintelligence), ClearML, Adversa AI, HEQA Security, NovaLink Space and Remondo, with prior exits including AppSee (ServiceNow), Revelator (Warner Music Group) and Splitit (ASX IPO). By pairing deep ecosystem experience with a timing-and-moat thesis, VentureIsrael backs Israeli deep-tech founders.

Ventures Platform is a leading Pan-African venture capital firm, renowned for its founder-friendly approach and substantial investments in tech-driven startups. With notable portfolio companies like Paystack, PiggyVest, and Remedial Health, Ventures Platform has a keen focus on fintech, health tech, edtech, and agritech sectors. Their geographic focus spans across Africa, targeting high-growth potential in emerging markets. The fund's investment strategy is characterized by early-stage investments, usually taking the lead in funding rounds, with average check sizes ranging from $50K to $500K. Ventures Platform emphasizes a hands-on approach, offering extensive portfolio support through their Platform and Networks team. This includes market analysis, ecosystem engagement, and strategic communications to ensure their portfolio companies scale successfully. To approach Ventures Platform, startups are encouraged to demonstrate innovative solutions with clear market potential, preferably in sectors aligned with the fund's focus. Building connections through ecosystem events and demonstrating strong growth metrics can significantly enhance the chances of securing investment.

VentureSouq is a dynamic venture capital firm based in Dubai, specializing in early-stage investments with a focus on FinTech and ClimateTech. Launched in 2013, VSQ has become a cornerstone of the MENA region’s entrepreneurial ecosystem, managing over 200 investments globally. Key investments include high-profile companies like Tabby, Sary, and Huspy, demonstrating their commitment to fostering innovation in diverse markets. VSQ targets sectors such as financial technology, climate technology, edtech, and digital media, emphasizing solutions that address critical economic, environmental, and societal issues. Their strategic focus includes sub-sectors like alternative proteins, carbon economy, energy storage, and supply chain technology, aligning with their mission of conscious investing. Geographically, VentureSouq invests across MENA and Pakistan, with notable ventures in the UAE, Saudi Arabia, Egypt, and Pakistan. Their regional approach is complemented by a global perspective, reflecting their expansive investment reach. VSQ's investment strategy revolves around thematic funds, aiming to support transformative tech startups from seed to growth stages. They actively lead funding rounds, often with substantial follow-on investments, and leverage their extensive network to propel startups toward significant milestones. Their portfolio management is hands-on, providing operational support, strategic guidance, and valuable industry connections. The leadership team includes co-founders Sonia Gokhale, Tammer Qaddumi, and Sonia Weymuller, all bringing a wealth of experience from various prestigious financial institutions. Their diverse backgrounds and deep sector expertise underpin VSQ's robust investment framework.

Verdane is a specialist growth investment firm focused on tech-enabled and sustainable businesses across Europe. Founded in 2003, Verdane has raised nine funds and several co-investment vehicles, with total commitments exceeding €6 billion. The firm invests in both single companies and portfolios, targeting two core themes: digitalization and decarbonization. Notable investments include Babyshop, Banqsoft, Baum und Pferdgarten, Bellman Group, and Bemz. Verdane's flexible investment approach allows for both minority and majority stakes, supporting companies through growth capital and strategic guidance. Their portfolio spans diverse sectors such as B2B software, consumer digital services, and green technology. Verdane operates from seven offices across Europe, including Berlin, Munich, Copenhagen, Helsinki, London, Oslo, and Stockholm. Their in-house team of over 130 professionals provides deep sector expertise and hands-on support to help portfolio companies scale and achieve market leadership. In recent years, Verdane has been recognized for its performance, notably being named the top-performing mid-market investor in Europe in 2022 by HEC-Dow Jones. The firm is also a certified B Corporation, ensuring its investments align with high sustainability standards.

Verissimo Ventures is a pre-seed and seed stage venture fund investing in technology startups across Israel, the US, and Europe. The firm focuses on backing founders who aim to solve significant problems using cutting-edge technology. Verissimo Ventures is particularly interested in vertical software, operational software, and engineering & infrastructure software, along with innovative business models targeting emerging and large markets​. Founded by Alex Oppenheimer, Verissimo brings a hands-on approach from day one, helping portfolio companies turn finance and operations into strategic assets. The team’s background spans operational finance, technology leadership, and R&D, with experience in guiding companies from founding stages through to IPO and M&A exits. This extensive experience allows them to provide invaluable support to their portfolio companies at every growth stage. The fund's portfolio includes companies such as Causal, Rossum, and Trullion, among others. Founders have praised Verissimo for their deep operational expertise, network, and strategic support, which have been critical in helping startups navigate early-stage challenges and achieve significant milestones.

Veritas Venture Partners is one of Israel's most experienced venture capital firms, founded in 1990 and based in Ra'anana. The firm manages around $100M across three funds, including VVP Fund II LP, and invests primarily in technology-based companies at the seed and very early stages, with selective participation through Series A and Series B; typical investment sizes range from about $1M to $3M, and it is willing to lead. Its focus areas have historically been internet and enterprise software, network and communications technology, and healthcare, with a portfolio spanning Israel and the United States. Over its history Veritas has made roughly 50 investments and recorded nine exits via acquisition. Notable portfolio companies and outcomes include Gilat Satellite Networks, acquired by Comtech Telecommunications in January 2020, Trivnet, a provider of mobile financial-services solutions for mobile network operators and banks, acquired by Gemalto in 2010, the storage technology company 3Ware, and Fring, a mobile communications service enabling free group video, voice calls and chat, in which Veritas led a $12M Series B round alongside North Bridge Venture Partners. The firm's partners have included co-founder Gideon Tolkowsky, founding partner Yadin Kaufmann, and partners Gill Zaphrir, Rann Marom and Laurie Olivier. As a long-established firm, Veritas has limited recent new-deal activity. With more than three decades of investing across Israeli and US technology, Veritas Venture Partners has backed internet, enterprise software, communications and healthcare founders from the seed and earliest stages.

Verity Venture Partners (VVP) is a consumer-focused VC firm that backs purpose-driven entrepreneurs building innovative brands. With a focus on early-stage startups, VVP invests in companies generating between $1-10M in revenue, often within beauty, wellness, personal care, food & beverage, and enabling technologies. The firm is led by co-founders Tina Bou-Saba and Matt Levin, both seasoned investors with deep experience in consumer goods and private equity. Tina has a track record of supporting high-growth brands and female entrepreneurs, while Matt brings over 27 years of expertise from Bain Capital. VVP's investment strategy revolves around high-impact partnerships with founders, offering not just capital but also strategic and operational support. They are highly selective, typically leading investment rounds, with a hands-on approach to scaling companies in underserved markets. Key investments include Arrae, Dae, and Cadence, reflecting their commitment to wellness and consumer tech. Headquartered in San Francisco, they are geographically focused on the U.S. and Canada, aiming to foster community and sustainability in their portfolio. Founders looking to engage with VVP should highlight alignment with their values of authenticity and purpose-driven growth, as the firm prefers to build deep, collaborative relationships early in a company's journey.

Versant Ventures, founded in 1999, is a leading venture capital firm with a strong focus on the healthcare and biotechnology sectors. Headquartered in San Francisco, the firm also has offices in Basel, New York, San Diego, Toronto, and Vancouver. Versant Ventures manages approximately $4.2 billion in assets and is known for its unique investment model, which includes both funding external companies and developing companies in-house through its discovery engines​. Versant Ventures has made significant investments in groundbreaking biotech companies. Some of their notable investments include CRISPR Therapeutics, a pioneer in gene editing; BlueRock Therapeutics, focused on cell therapy; and precision oncology firms like Black Diamond Therapeutics and Repare Therapeutics. These companies have achieved substantial success, with several going public and making significant advancements in their respective fields​​. The firm's strategy involves creating and nurturing startups from the ground up, providing not only financial support but also access to state-of-the-art laboratories and multidisciplinary teams of scientists. This approach has enabled Versant Ventures to foster innovation and drive the development of novel therapeutics and biotechnology solutions​. For entrepreneurs and startups in the biotech and healthcare sectors, Versant Ventures offers a robust support system and a track record of successful exits and IPOs, making it a key player in advancing medical and scientific breakthroughs.

Version One Ventures is a venture capital firm that focuses on backing mission-driven founders at the earliest stages of their ventures. Established by Boris Wertz and Angela Tran, the firm is based in Vancouver and San Francisco. Version One invests in a diverse range of sectors, including SaaS, marketplaces, crypto, and climate/energy. Notable investments include companies such as Coinbase, Ada, Shippo, Uniswap, and Jobber. The firm has a reputation for identifying high-potential opportunities early, having successfully invested in vertical SaaS in the early 2010s, crypto since 2016, and climate tech starting in 2020. Version One Ventures is driven by a core belief in supporting founders who are creating transformational change and new market categories. They seek out opportunities that might seem fringe or emerging but have the potential to lead and define new industries. This approach has led them to invest in areas like AI, VR/AR, and hardtech/biotech.

Vertex Growth, founded in 2019, is a growth-stage venture capital firm based in Singapore, dedicated to backing high-potential companies across Asia and globally. The firm focuses on scaling technology and healthcare startups, providing them with both capital and strategic support. As part of the Vertex global network, which includes affiliates in regions like Southeast Asia, Israel, Japan, and the US, Vertex Growth taps into a broad ecosystem, leveraging this network to help its portfolio companies reach their full potential. The fund typically invests in Series B and beyond, with a ticket size ranging from $10 million to $15 million. It focuses on sectors such as fintech, healthcare, cybersecurity, and deep tech, and has invested in prominent companies like Nium, PerimeterX, and Allay Therapeutics. With over $760 million under management and a portfolio of more than 30 companies, Vertex Growth is committed to creating category-defining companies. The firm also boasts a strong track record of exits, including successful investments in Sunday and PatSnap. The firm’s leadership, including General Partners James Lee, Tam Hock Chuan, and Jeff Chang, emphasizes a hands-on approach, working closely with entrepreneurs to drive value creation beyond capital investment​.

Vertex Ventures is a global network of venture capital funds with a focus on early-stage investments across various innovation hubs, including China, Israel, Southeast Asia, India, the US, and Japan. Vertex Ventures Japan (VVJ), the newest addition, recently launched its inaugural JPY 10 billion ($64 million) fund, Vertex Ventures Japan Fund I (VVJFI). This fund is dedicated to investing in early-stage Japanese startups with high growth potential, particularly in sectors such as deep tech, digital transformation (DX), artificial intelligence (AI), and the creator economy​. VVJ leverages the extensive global network of Vertex Holdings, which manages over $6 billion in assets and provides strategic support and operational assistance to its portfolio companies. This network allows VVJ to offer Japanese startups access to global markets and resources, fostering innovation and technological advancement​. The fund is led by Managing Partner Takashi Tomita and General Partner Tomohiro Miyasaka, who are responsible for identifying new investment opportunities and driving strategic growth. Vertex Ventures Japan also collaborates with the University of Tokyo and the Japanese government to enhance the startup ecosystem through cross-border partnerships between industry, academia, and government.

Vertex Venture Holdings (Vertex Holdings) is a Singapore-based venture capital investment holding company and a wholly-owned subsidiary of Temasek Holdings. Founded in 1988, it is one of Singapore's largest and oldest VC platforms. Originally the corporate venture arm of engineering conglomerate Singapore Technologies, it was acquired by Temasek in 2004 after an earlier fund network unwound following the dot-com bust. Rather than operating as a single fund, Vertex Holdings acts as an anchor investor and operational backbone for a proprietary global network of separately and independently managed VC funds. There are seven network partnerships: Vertex Ventures China, Vertex Ventures Israel, Vertex Ventures SEA & India, Vertex Ventures US, Vertex Ventures Japan, Vertex Ventures HC for healthcare and Vertex Growth. The family of funds invests in early-stage technology opportunities through the Vertex Ventures funds, early-stage healthcare through Vertex Ventures HC, and growth-stage opportunities globally through Vertex Growth. Across these funds, Vertex manages roughly USD 6.8 billion in assets and counts more than 300 active portfolio companies. Notable successes include Grab, PatSnap, Nium, Instarem, FirstCry, XPressBees, Licious, 17LIVE and CyberArk. In 2024 its activity leaned heavily toward India, which accounted for roughly two-thirds of investments amid a surge of capital-efficient startups. The platform is led by Group President and CEO Chua Kee Lock, and it emphasizes value creation beyond capital, helping portfolio companies with cross-border expansion and new-market entry. As Temasek's anchor venture platform, Vertex Venture Holdings underpins a global network of funds backing technology and healthcare founders.

Vesalius Ventures is a Houston, Texas-based venture capital firm founded in 2002, dedicated to accelerating the future of medicine by investing in early- to mid-stage healthcare technologies. It began as a VC accelerator focused on medical informatics and telemedicine, working closely with management teams and entrepreneurs, and has since grown into a diversified firm targeting large but unmet market needs, compelling technologies and superior companies. Beyond core digital health and medical informatics, its interests span information technology, telecommunications and energy. The firm operates through several entities: Vesalius Ventures Accelerator, Vesalius Capital Group, Vesalius Health Advisors and Vesalius International, supporting the development and commercialization of advanced technologies, generally as a co-investor. It was established through investments from three venture and corporate partners, Vanguard Ventures, Fremont Ventures and Guidant Corporation, now Boston Scientific, and was joined a year later by Sevin Rosen Funds. The firm is led by Dr. Bernard A. Harris Jr., CEO and Managing Partner, a former NASA astronaut and the first African American to walk in space, who is also a fellow of the American Telemedicine Association and previously worked with the $500M early-stage firm Vanguard Ventures. Portfolio themes include mobile cardiac telemetry, FDA-cleared medication-free treatment for panic disorder and PTSD, sepsis detection and contact-free post-acute biosensors such as Prevenir Health. Notable historical investments include Health Hero Network and LifeOnKey. The firm runs a small, focused team. By pairing capital with deep healthcare and telemedicine expertise, Vesalius Ventures backs early- to mid-stage medical-technology companies addressing large unmet needs.

VestedWorld is a Chicago-based venture capital firm focused on catalyzing growth in emerging markets, particularly in Sub-Saharan Africa. Founded with a mission to drive sustainable economic development, VestedWorld invests in early-stage companies across sectors such as agribusiness, consumer products, and technology-enabled services. The firm's strategy emphasizes identifying high-growth potential businesses that can create significant economic and social impact in regions often overlooked by traditional investors. VestedWorld operates with a strong belief that the most effective way to alleviate poverty is through economic development. By channeling capital into promising startups in countries like Kenya, Nigeria, and Ghana, the firm aims to foster entrepreneurship, create meaningful jobs, and support the broader economic ecosystem. VestedWorld's approach is not just about providing financial returns to its investors, but also about contributing to the overall prosperity and stability of the regions it invests in. The firm’s leadership, including Managing Director Euler Bropleh, brings extensive experience in both venture capital and emerging markets. They maintain a hands-on approach, working closely with portfolio companies to help them scale and succeed in challenging environments. VestedWorld's impact-driven investment model allows investors to "do well by doing good," aligning financial success with positive social outcomes. With a clear focus on sectors critical to economic development, such as agriculture and technology, VestedWorld is committed to making a transformative impact in some of the world's fastest-growing but undercapitalized markets.

Vestel Ventures is the corporate venture capital arm of Vestel Elektronik Sanayi ve Ticaret, part of Turkey's Zorlu Holding conglomerate, founded in 2015 and based in Istanbul. It operates with an evergreen fund structure, meaning it has no fixed fund size, and invests primarily at Seed and Series A stages. The firm targets early-stage deep-tech companies with strategic collaboration potential aligned to the sectors in which Zorlu, Vestel and group companies operate. Its focus areas span healthcare, productivity, human-resource tech, media, artificial intelligence, retail, cybersecurity, smart city, biotech and energy, along with nanomaterials, mobility and automotive technologies. As a strategic CVC, it goes beyond capital, mobilizing Zorlu Holding's resources, communication network and infrastructure to support entrepreneurs across all stages of product development, including design, prototyping, testing, certification and production, as well as marketing, global sales, legal and accounting, generally as a co-investor. Up until November 2024 it had invested in roughly 28 startups, with third-party trackers reporting between 36 and 47 deals, located not only in Türkiye but also in France, the UK and the USA. In 2022 it partnered with Tacirler Portfolio Management to establish the Gelecek Etki Fonu (Future Impact Fund), a venture capital investment fund. Notable portfolio companies include Haystack TV, CYVision, SCADAfence, Onlayer, Dengage and Splitvolt. The firm runs a small team of about six people, including two partners. By pairing evergreen capital with Zorlu Holding's industrial resources, Vestel Ventures backs early-stage deep-tech founders whose technologies align with the group's businesses.

Vestigo Ventures is an early-stage venture capital firm based in Cambridge, Massachusetts, that focuses on fintech startups. Founded by David Blundin, Mark Casady, and Ian Sheridan, the firm aims to support transformative innovations in financial technology. Vestigo Ventures manages Fund I with $58.9 million, concentrating on market structures, operational solutions, worksite management, and personal wealth management. The firm leverages its connection with Cogo Labs, a data-driven startup incubator, to provide extensive support to its portfolio companies. Vestigo Ventures has invested in notable startups like Digital Assets Data, LifeYield, and Micronotes. The team includes experienced professionals like Managing Partner Mike Nugent and Partner Frazer Anderson, who bring a wealth of expertise in fintech and venture capital. Vestigo Ventures’ strategic limited partners comprise corporate investors from the insurance and asset management sectors, family offices, and individual investors from the financial services industry. This diverse LP base provides portfolio companies with invaluable industry insights and operational experience. Overall, Vestigo Ventures stands out for its focused investment strategy in fintech and its commitment to accelerating the growth of early-stage companies through data-driven insights and strong industry connections.

Vibe Capital is a venture fund founded by Ankur Nagpal, known for its focus on early-stage investments in technology-driven startups. The fund's strategy is centered on identifying and supporting innovative companies, particularly those in emerging markets like India, Brazil, and across Africa, reflecting a belief in the transformative power of venture capital in these rapidly growing regions. Vibe Capital has raised two funds so far: the first at $12 million and the second at $70 million, with a significant portion of investments directed outside the U.S. The fund targets sectors like AI, Web3, and deep tech, emphasizing a proactive approach to wellness, financial innovation, and entrepreneurship-enabling platforms. What sets Vibe Capital apart is its no-management-fee structure, ensuring that all raised capital is directed into startups, with a third of the fund's capital coming from the founders themselves. The fund is particularly attractive to entrepreneurs due to the hands-on experience of its team, who are all former founders and operators, providing invaluable support in growth, marketing, and go-to-market strategies. The fund’s network is another strong point, with ties to prominent investors and firms like Bessemer and General Catalyst, offering startups crucial connections for future fundraising.

Vice Ventures is a Brooklyn, New York-based early-stage venture capital firm founded in 2018 by sole General Partner Catharine Dockery to systematically invest in 'good companies operating in superficially bad industries,' verticals that mainstream institutional capital tends to avoid because of social stigma, regulatory complexity or moral panic. Dockery built the firm after time on Walmart's retail M&A team focused on digitally-native vertical brands, with earlier experience in equity trading and high-yield credit research. The investable universe explicitly includes alcohol and beverages, cannabis, harm-reducing nicotine, psychedelics including legitimate clinical-stage MDMA and ketamine therapeutics, sex tech and sexual wellness, skill-based and sports betting, and emerging vices. Vice Ventures closed its $25M Fund I in 2019 and the firm's $25M Fund II soon after, while preserving a small, founder-aligned operating model with a single GP, and it generally invests as a co-investor. Across approximately 14 to 15 investments to date Vice Ventures has built a portfolio that includes CBD beverage brand Recess, alternative-nicotine pouch brand Black Buffalo, harm-reducing inhalation platform Qnovia, its most recent disclosed investment in Qnovia's Series B on November 12, 2024, and direct-to-consumer intimates and women's wellness brand Parade, which became Vice's highest-profile exit when it was acquired on August 15, 2023. The fund primarily participates in Seed rounds in US-based companies. By deliberately backing strong companies in stigmatized but large categories, Vice Ventures pursues returns in markets that conventional investors overlook.

Vickers Venture Partners is a Singapore-headquartered global deep-tech venture capital firm founded in 2005 by Chairman and Founder Dr. Finian Tan together with co-founders Dr. Khalil Binebine, Dr. Jeffrey Chi (Vice Chairman), Dr. Damian Tan, Linda Li and Raymond Kong. From its Singapore base, Vickers operates a true global network with offices in Shanghai, Hong Kong, New York, Miami, Silicon Valley and London. The firm manages approximately $3 billion across six funds and structured co-investment vehicles, including a more than $250 million Fund VI announced in December 2021 with a sharpened deep-tech focus, and it is willing to lead. Its investment mandate centers on disruptive technologies addressing the world's biggest challenges, life sciences and therapeutics, biotech, renewable and clean energy, nanotechnology and advanced materials, applied AI, fintech, and selectively media, telecommunications and consumer, across all major geographies. Across approximately 60 portfolio companies as of December 2024, Vickers has delivered three IPOs and six acquisitions, with named winners including direct-to-consumer apparel pioneer Bonobos, acquired by Walmart, Canadian geothermal energy company Eavor, whose $15M Series A Vickers led in September 2019 as the firm's first Canadian deal, and Aardvark Therapeutics, where Vickers led Series A and B and remained in the $85M Series C of May 2024 before Aardvark's February 2025 NASDAQ IPO at a $342M market cap. Other historic names include Baidu, Focus Media and Scilex Holdings, contributing to a cumulative portfolio market value the firm cites at over $100 billion. Vickers backs global deep-tech founders solving large challenges.

VIGO Ventures (formally VIGO We Innovation sp. z o.o.) is a Warsaw-based alternative investment fund founded in 2017 as a 50:50 joint venture between Polish photonics champion VIGO Photonics, a global leader in high-operating-temperature infrared detectors, and Warsaw Equity Group, a privately held investment firm with more than two decades of operating-investment experience. The fund's distinctive thesis is sharply focused on hardware deep tech, photonics and optics, semiconductor and chip design, automation and robotics, photovoltaics and clean energy, and materials engineering, with selective adjacent activity in advanced sensing, machine vision and applied AI. By giving Polish and broader European deep-tech founders access to VIGO Photonics' manufacturing know-how and customer base alongside capital, VIGO Ventures effectively functions as a strategic-CVC-plus-VC hybrid, generally investing as a co-investor. Adam Piotrowski, Chairman of the Management Board of VIGO Photonics, sits on the Supervisory Board of VIGO We Innovation. Across approximately 10 disclosed portfolio companies the fund has invested across Poland, Germany, Belgium and the Netherlands, with named names including Deep Detection in sensing, QustomDot in quantum-dot materials, supported in a EUR 2.7M round in November 2024 with EIC accelerator co-funding, Dutch integrated-photonics specialist PHOTON IP, ObvioHealth in decentralized clinical trials, and Fluence, VIGO's most recent reported investment on August 20, 2025 in a Seed-II round. By coupling capital with VIGO Photonics' deep-tech manufacturing expertise, VIGO Ventures backs European hardware, photonics and semiconductor founders.

VilCap Investments, founded in 2014 and headquartered in San Francisco, focuses on early-stage impact investing, backing companies that address pressing social and environmental challenges. Their portfolio spans various sectors, including health, education, energy, agriculture, and financial services. Notable investments include Bodhi Health Education, Certintell, Constant Therapy, and iKure in the health sector, and MPOWER Financing, Nepris, and Pear Deck in education. VilCap's investment strategy is deeply rooted in impact, aiming to create long-term prosperity and equity. They typically invest in seed and early-stage companies, with a preference for those that align with their mission of fostering social and environmental change. VilCap Investments often collaborates with Village Capital’s accelerator programs to find and fund innovative entrepreneurs. The firm’s geographic focus includes the United States, India, Africa, and Latin America, reflecting their commitment to global impact. Their investments range from $150,000 to $500,000 in follow-on funding, emphasizing support for high-performing companies. Key team members include Michael Davis, Managing Director, and Victoria Fram, co-founder and advisor. VilCap prefers to be approached through their network, leveraging connections to identify potential investments that align with their values and impact goals​. For startups aiming to engage with VilCap, highlighting a strong alignment with social and environmental impact, alongside a solid business model, will be crucial. Their unique approach blends financial support with strategic guidance to ensure long-term success and sustainability.

Village Global is an early-stage venture capital firm that leverages a robust network of luminary investors to back innovative entrepreneurs from the very start. Based in San Francisco, the firm has garnered support from tech giants like Jeff Bezos, Bill Gates, Mark Zuckerberg, and Reid Hoffman, who also serves as the firm's Chairman​. Village Global focuses on a wide array of industries, including fintech, health, consumer, and enterprise technology. Their portfolio boasts successful investments in companies such as Kapwing, Pogo, and Stitch, highlighting their commitment to backing transformative and high-potential startups​. The firm's investment strategy involves leading pre-seed and seed funding rounds, typically writing checks between $250,000 and $1.5 million. Village Global is noted for its network-centric approach, offering unparalleled access to mentors, follow-on funding, and strategic advice from some of the world's most successful entrepreneurs​. With over $500 million in assets under management, Village Global's team includes influential figures like Anne Dwane and Ben Casnocha, who actively support their portfolio companies through hands-on guidance and connections. For startups looking to partner with Village Global, demonstrating a bold vision and the potential for significant impact is crucial. The firm's unique network-driven model provides startups with the resources and support needed to accelerate their growth from day one.

Vine Ventures, founded in 2019 by Ryan Zurrer, is a venture capital firm headquartered in Zurich, Switzerland, with a strong focus on early-stage investments in the life sciences and technology sectors. The firm has a particular interest in innovative solutions for mental health and wellness, emphasizing the development of psychedelic therapies and healthcare technology systems. Notable investments from Vine Ventures include companies like Alto Neuroscience, which recently went public, and Kocomo, a proptech startup based in Mexico City. Vine Ventures has also backed Remepy, Lykos Therapeutics, and Necto, demonstrating their commitment to advancing healthcare and financial software solutions. Geographically, Vine Ventures invests in the U.S., Latin America, and Israel, reflecting their global reach and diversified portfolio. Their strategic approach involves leading funding rounds and providing substantial support to help startups scale and achieve significant milestones​. The Vine Ventures team boasts experienced professionals like Daniel Tarockoff and Ozan Polat, based in San Francisco and Zurich respectively. Ryan Zurrer, the founder, has a robust background in venture investing and entrepreneurship, particularly in the renewable energy and blockchain sectors. This diverse expertise allows the firm to offer valuable insights and hands-on support to their portfolio companies​. For startups aiming to collaborate with Vine Ventures, it's essential to present innovative, scalable solutions that align with their focus areas. Direct, concise pitches that demonstrate clear market potential and strategic fit are highly valued by the firm. By fostering a collaborative environment and leveraging their extensive network, Vine Ventures continues to drive impactful advancements in the health and wellness sectors.

Virtue VC is an early-stage venture capital firm based in Austin, Texas, that focuses on transforming healthcare through pre-seed and seed-stage investments. Launched in 2021, the firm typically invests between $250,000 and $1 million in healthcare startups, often committing within 7-10 days. Virtue is deeply involved with its portfolio companies, offering patient capital and hands-on support, helping founders with everything from go-to-market strategies to scaling their ventures. Virtue’s portfolio includes a range of innovative companies like Evvy, which focuses on precision vaginal microbiome care, and Amae Health, a value-based care provider for serious mental illnesses. Other standout companies include Mural Health, working on clinical trials infrastructure, and Ryght Ai, specializing in biopharma insights and analytics. Led by Sean Doolan, a veteran in healthcare investment, and Emre Karatas, who brings a focus on digital health and commercialization strategies, Virtue VC targets founders who aim to radically reshape healthcare, rather than just improve existing systems​. They primarily focus on U.S. companies but are open to global opportunities.

Visible Hands is a pre-seed venture capital fund and accelerator dedicated to supporting underrepresented founders, particularly women and people of color, in building successful tech startups. Founded in 2020, Visible Hands offers a 14-week accelerator program that provides founders with up to $200,000 in funding, alongside comprehensive company-building services. The program focuses on helping founders navigate the early stages of their entrepreneurial journey by offering tailored support, including branding, sales coaching, and mentorship. Visible Hands has gained a strong reputation for its commitment to diversity and inclusion, investing in founders who have often been overlooked by traditional VC firms. The firm's portfolio includes a diverse range of startups, with a significant percentage of its founders identifying as Black, African American, and Latinx. The fund recently closed an oversubscribed Fund I at $10.5 million, reflecting the growing interest in its mission and approach. Visible Hands also runs city-specific fellowship programs, such as VHNYC in New York and VHBOS in Boston, which focus on local, early-stage entrepreneurs from diverse backgrounds. The firm's impact-driven approach not only aims to generate financial returns but also to create meaningful social change by empowering underrepresented founders to succeed in the tech industry.

Visible Ventures is a venture capital firm that invests in early-stage companies, emphasizing human-centric solutions that drive significant cultural and economic outcomes. Their investment strategy focuses on supporting innovative startups across various sectors, including health, education, fintech, and consumer products. They are particularly committed to championing underrepresented founders, with a strong emphasis on diversity, equity, and inclusion. The firm's portfolio includes notable companies such as Illumix, an augmented reality platform; Ello, a social network for creative communities; Recurate, a recommerce platform for brands; and WaitWhat, a media invention company. Visible Ventures provides not only capital but also strategic guidance, operational support, and a robust network to help their portfolio companies scale and succeed. The team at Visible Ventures consists of experienced investors, operators, and advisors dedicated to supporting early-stage companies and helping them achieve their goals.

Vision Ventures is an early-stage venture capital firm with a focus on supporting bold entrepreneurs across various sectors, particularly in Central and Eastern Europe (CEE). The fund's portfolio spans industries such as AI, SaaS, HR tech, and robotics, featuring notable investments like Sloneek, Airvolute, and BiteBerry. These companies exemplify Vision’s focus on innovation, automation, and simplifying business operations globally. Vision Ventures primarily invests in pre-seed and seed rounds, with an average check size of up to EUR 1.6 million. The firm seeks startups with the potential to scale globally, providing not only financial backing but also strategic advice on growth and market positioning. Vision Ventures takes a hands-on approach, often helping with product development and strategic decisions. Geographically, Vision Ventures is rooted in Slovakia, but their investments and partnerships are spread across Europe, with an increasing interest in global opportunities. Founders should approach Vision Ventures with a clear market strategy and scalability plan, as they highly value data-driven growth models and visionary leadership. The team, led by serial entrepreneur Tomáš Bél, is known for its strong business acumen and deep experience in various industries, making them a reliable partner for navigating the complexities of early-stage growth. In short, Vision Ventures offers much more than capital—they are deeply involved in guiding companies to success, offering expertise across finance, technology, and market development.

Visionnaire Ventures is a San Francisco-headquartered global technology venture capital firm founded in 2013 to back visionary founders building world-class, market-leading technology companies. The firm was co-founded by Managing Partner Susan Choe and Chairman Taizo Son, the Japanese serial entrepreneur and younger brother of SoftBank's Masayoshi Son who founded GungHo Online Entertainment, the company behind Puzzle & Dragons, which IPO'd in 2005, and who today also runs Mistletoe Inc., a global investment and innovation platform. Visionnaire's senior team also includes Managing Director Keith Nilsson, a former partner at TPG Growth, plus operational-investing leaders from Mistletoe. The firm is SEC-registered and manages less than $150M of AUM across two private funds, generally investing as a co-investor. Its investment thesis covers global next-generation technology businesses leveraging artificial intelligence and deep learning, robotic automation and visual perception, agricultural technology, digital health, mobility, big data and IoT. Across 53 disclosed investments the firm has produced 16 portfolio exits and one unicorn, with named investments including online shopping intelligence and savings platform Price.com, its most recent investment in March 2021, automated closed-loop insulin delivery company Bigfoot Biomedical, a Series B participant in 2017 that exited in September 2023, and creator-marketing platform Captiv8 Labs, acquired by Publicis Groupe in May 2025. The team brings deep operating experience from global internet, gaming and online media companies. By pairing capital with that operating expertise, Visionnaire Ventures backs founders building next-generation AI, robotics, agtech and digital-health companies worldwide.

VITALIZE Venture Capital, founded in 2017 and based in Chicago, focuses on early-stage investments in WorkTech, emphasizing people-first, data-driven innovations that transform work outcomes. Their portfolio includes a range of companies like Plumb, Mobly, and Lucia, operating in diverse sectors such as software development, productivity tools, and information services. Led by founder Gale Wilkinson, the team also includes Justin Gordon and Caroline Casson, who bring extensive experience in venture capital and startup incubation. VITALIZE supports startups through its $23.4M Fund II and a community of over 500 angel investors, offering capital and strategic guidance. The firm is committed to fostering diversity, with 70% of their angel investors coming from underrepresented backgrounds. VITALIZE Angels, their angel investing arm, allows both accredited and non-accredited investors to participate, promoting broad access to venture capital opportunities.

Vodafone Ventures is the strategic corporate venture capital arm of London-listed telecommunications giant Vodafone Group plc, founded in 2000 and operated today out of Vodafone's Vodafone xone innovation office. The unit began life with a US-based research laboratory in California that incubated early-stage companies on Vodafone's behalf, and consolidated its primary operating footprint into Vodafone's London headquarters in 2014. Vodafone Ventures' mandate is to make strategic minority investments in startup, seed, early- and mid-stage companies whose technology meaningfully advances Vodafone's core wireless, internet and enterprise digital businesses. Sector focus covers IoT, cloud and edge infrastructure, healthcare technology, consumer products and services, enterprise SaaS, devices, and adjacent telco-relevant deep tech. Tickets are typically sized between £2M and £10M, often deployed alongside top-tier financial VCs in Series A through D rounds, with portfolio composition split across Consumer, Enterprise, Infrastructure and Devices, generally as a co-investor. Across more than 34 disclosed investments and 17 portfolio exits, named outcomes include AST SpaceMobile, a direct-to-cell satellite operator now NASDAQ-listed, 5G mobile core software vendor Affirmed Networks, acquired by Microsoft in 2020 for roughly $1.35B, customer-experience platform Qualia, events platform Eventtus, object-storage company Caringo, and advertising platform Amobee. Publicly tracked team members include Senior Director Christina Ku, Partner Matthew Fix and investment professional Roshni Srinivasan. By pairing capital with the engineering knowledge and customer channels of a global telecom operator, Vodafone Ventures backs the technologies advancing connectivity, cloud, IoT and enterprise digital services.

Vodia Ventures, the investment arm of Vodia Capital, is a Massachusetts-based venture capital firm that focuses on early-stage investments in companies developing technology-enabled solutions for social and environmental challenges. Founded in 2013, Vodia Ventures targets sectors such as clean energy, healthcare, food security, and sustainable infrastructure. The firm is particularly interested in scalable, impactful technologies that address pressing global issues like climate change and resource scarcity. Vodia Ventures operates by creating specialized investment vehicles such as blind pool and SPV (Special Purpose Vehicle) funds. Their goal is to provide early-stage capital to innovative startups, helping them grow while making a positive impact on society. Some of the industries Vodia Ventures invests in include technology, clean energy, healthcare, and smart infrastructure. Under the leadership of founder David B. Matias, Vodia Ventures continues to play a significant role in fostering innovation by supporting companies that align with its mission of social impact​.

Voima Ventures is a Helsinki and Stockholm-based deep technology venture capital firm founded in 2019 by Inka Mero, Founder, CEO and Managing Partner, together with Marko Viinikka and Mikko Kumpulainen, to back science-driven Nordic and Baltic startups solving major global problems. The firm sits at the intersection of academic spin-outs, applied research and entrepreneurial capital, and is one of the only science-centric VC investors in the region with a published multi-fund track record, and it is willing to lead. Voima's investable universe spans bio and new materials, medical technology and life sciences, imaging and optics, IoT and electronics, robotics, software and ICT, AI, clean energy and food. The 16-person team includes Partners Jussi Sainiemi, previously Investment Director at Finnish Industry Investment with deep-tech wins including ICEYE and Oura, Pontus Stråhlman, Investment Director Jenny Engerfelt and two venture partners, distributed across Helsinki and Stockholm. In December 2024 Voima finalized Fund III at over EUR 100M, dedicated to Nordic and Baltic deep-tech founders. Across approximately 54 disclosed investments, with 30 active in Funds I and II at the announcement of Fund III, the firm has produced 5 exits and 1 IPO; named portfolio names include Finnish gas-fermentation alternative-protein maker Solar Foods, AR display waveguide company Dispelix, low-carbon cement Betolar, single-cell protein producer EniferBio, oncology platform MVision, and most recently Quantagonia, which exited in August 2025. By backing science-driven founders across the Nordics and Baltics, Voima Ventures commercializes deep-tech research into global companies.

VoLo Earth Ventures is a climate-focused VC fund that backs early-stage tech startups aiming to accelerate the energy transition. With a portfolio that spans industries like energy, mobility, and industrial decarbonization, VoLo has led investments in innovative companies such as Rain, which builds aerial firefighting technology, and Magrathea Metals, which is pioneering metal production from seawater. VoLo’s strategy revolves around hands-on involvement, particularly in the early stages, offering both first-in capital and leadership to help startups scale rapidly. They focus primarily on North America, investing in climate tech solutions across sectors like renewable energy, grid infrastructure, sustainable mobility, and carbon-negative technologies. The fund actively seeks founders with bold ideas to combat climate change and encourages direct outreach from entrepreneurs who align with their vision. The average check size is undisclosed, but their involvement in leading rounds, such as a $7M Series A for Daanaa, shows they are comfortable leading significant rounds. VoLo Earth’s team brings deep expertise, led by Managing Partner Kareem Dabbagh, who has a background in solar energy startups like SolarCity and Sunrun. The fund's mission is to deliver superior returns while maximizing carbon impact, and they pride themselves on rigorous technical due diligence to ensure that investments not only scale financially but also push the envelope on sustainability. VoLo is highly selective, targeting innovations that deliver measurable carbon benefits while yielding unsubsidized economic returns.

Plus Venture Capital (+VC) is a prominent seed-stage fund with a laser focus on tech and tech-enabled startups across the MENA region and its diaspora. Founded by Hasan Haider and Sharif El-Badawi in 2020, the firm leverages its deep experience in building and scaling startups to back high-potential companies. Notable portfolio companies include Educatly, a B2C information service platform, Thndr, a fintech startup, and Suplyd, which focuses on digital logistics solutions​. +VC’s strategy is to lead investments at the seed stage, often continuing support through Series A, providing startups with capital and hands-on mentorship. Their emphasis is on scaling companies with innovative, future-proof solutions, primarily within fintech, healthtech, SaaS, and e-commerce sectors. The firm has a strict geographic focus on the MENA region, with an openness to founders in the global diaspora. Average check sizes vary depending on the stage, but the firm is known for being founder-friendly and expedient in decision-making. Their co-founders have a wealth of operational experience, having navigated their own startup failures and successes. The team, headquartered in Abu Dhabi, is led by Haider, El-Badawi, and principal Zainab Al Sharif.

Vorwerk Ventures is an independent €150 million venture capital fund based in Berlin, with a strong focus on consumer-centric businesses and digital technologies. Originally grown out of the Vorwerk Group in 2019, the firm invests in early-stage companies, typically from pre-seed to Series A, with check sizes ranging from €500,000 to €10 million. They emphasize sectors such as consumer goods, fintech, and health tech, with a focus on companies that are innovating in the digitalization of traditional industries. Vorwerk Ventures has an impressive track record, including investments in companies like HelloFresh, Flaschenpost, Everdrop, and Zapp. They not only provide capital but also offer extensive support in business development, strategy, and operations to help their portfolio companies grow. Their investment approach focuses on finding strong founding teams and consumer-centric business models that target substantial markets. As part of their strategy, Vorwerk Ventures reserves up to €15 million for follow-on financing rounds to ensure continuous support for high-potential companies.

VSC Ventures is a venture capital firm based in San Francisco, founded by Vijay Chattha and Jay Kapoor. The firm leverages its 20+ years of experience in public relations to offer a unique blend of investment and storytelling expertise. VSC Ventures specializes in Seed and Series A investments, focusing on three main sectors: the future of work, wellness and bio, and world-saving climate technology. VSC Ventures differentiates itself by using its storytelling capabilities to help portfolio companies gain visibility with customers, investors, and employees. With a $21 million fund, the firm has already made significant investments in startups like Sesame Solar, Graphwear, Pepper Bio, and Goodcall. Their strategy is to provide both capital and communications support to help startups scale and stand out in an increasingly competitive market. In addition to financial backing, VSC Ventures works closely with founders to refine their messaging, go-to-market strategies, and media presence. This hands-on approach has proven successful for startups that benefit from their comprehensive media and PR expertise alongside traditional venture capital support.

squared Ventures, a Munich-based venture capital firm, focuses on early-stage deep tech investments across Europe. Established in 2016, Vsquared Ventures aims to back scientific and engineering-based innovations that address global challenges. Their areas of focus include AI, next-generation software, energy transition, new computing and sensing, new space, robotics, and tech-bio sectors. The firm recently closed its second fund, Vsquared II, at €214 million, making it the largest early-stage deep tech fund in Europe. This fund will support approximately 25 companies with investments ranging from €500,000 to €5 million, with a significant portion reserved for follow-on investments. Notable investments by Vsquared include Isar Aerospace, a rocket manufacturer; IQM Quantum, a quantum computing hardware provider; and Neura Robotics, a developer of cognitive robotic assistants. The firm is committed to leveraging Europe's strong talent pool and research facilities to build category-leading companies. The team at Vsquared Ventures includes experienced investors and deep tech experts, such as Thomas Oehl, Dr. Herbert Mangesius, and Dr. Lise Rechsteiner, who joined as a General Partner for the latest fund​. They focus on fostering a resilient deep tech ecosystem in Europe, aiming to make significant contributions to technological and economic sovereignty.

VU Venture Partners is a global multi-stage venture capital firm founded in 2018, with headquarters in San Francisco and Hong Kong. The firm is focused on seven key verticals: Consumer, Enterprise, Fintech, Frontier, Healthcare, PropTech, and Web3. With a robust global presence, VU operates in major markets across North America, Europe, Asia-Pacific, and Africa. The firm distinguishes itself through its large, diversified investment team of over 70 professionals, allowing them to source around 20,000 deals annually, a scale far greater than typical venture firms. VU Venture Partners invests in early-stage companies from pre-seed to Series A, making initial investments between $200K and $1M, with the ability to follow up with investments of up to $10M. The firm supports portfolio companies through long-term partnerships, helping them with customer acquisition, strategic introductions, and fundraising, while also reserving capital for follow-on investments. VU has a strong track record of identifying future unicorns, having previously invested in companies such as Uber, Facebook, Venmo, and Beyond Meat. The firm also runs the Venture University accelerator program, which provides individuals with the opportunity to gain real-world investment experience, participate in deal flow, and build their own investment track records while contributing to VU’s success.